CYP1A1 and prostate carcinoma: Furthermore, our studies identified cg12101586 (CYP1A1) to be significantly associated with increased risk of prostate cancer and breast cancer, suggesting the smoking‐related methylation at cg12101586 potentially affected the expression of CYP1A1, thus consequently increased the risk of cancers at both sites of prostate and breast.